Alpine Global Management, LLC Karuna Therapeutics, Inc. Transaction History

Alpine Global Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 06, 2024	BUY	$176.32 - $240.22 $212,465 - $289,465	1,205 New	1,205 $261,000
Q2 2023 Nov 21, 2023	BUY	$176.32 - $240.22 $212,465 - $289,465	1,205 New	1,205 $261,000
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $212,465 - $289,465	1,205 New	1,205 $261,000
Q4 2020 Feb 12, 2021	SELL	$75.23 - $109.23 $316,567 - $459,639	-4,208 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$71.31 - $109.74 $300,072 - $461,785	4,208 New	4,208 $325,000
Q1 2020 Apr 09, 2020	SELL	$60.41 - $115.92 $196,513 - $377,087	-3,253 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$11.44 - $123.99 $37,214 - $403,339	3,253 New	3,253 $245,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.